One-Step Universal Adhesives: A 3-year Clinical Trial in Class II Composite Restorations

May 5, 2025 updated by: Omar Abd El-fattah, Mansoura University

One-Step Universal Adhesives: A 3-year Randomized Comparative Clinical Trial in Class II Composite Restorations

to evaluate and compare the clinical performance and periodontal responses of four commercially available one-step universal adhesives with different formulations in Class II composite restorations over a three-year period.

Study Overview

Detailed Description

The experimental design description adhered to the guidelines provided by the Consolidated Standards of Reporting Trials (CONSORT) statement. The present study is planned as a double-blinded randomized clinical trial, ensuring that both the patients and the examiner are unaware of the treatment allocation. The trial will follow a split-mouth design. A total of forty-eight adult patients, who are seeking dental treatment, will be enrolled in the study. The participants will be recruited from the Outpatient clinic at Faculty of Dentistry, Mansoura University.

No active advertisement will be used for participant recruitment, and instead, a convenience sample will be formed. Prior to participating in the study, each patient will be required to provide informed consent by signing a consent form. The protocol of the study was approved by Mansoura University's ethics committee before initiation

Study Type

Interventional

Enrollment (Estimated)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Dakahlia
      • Mansoura, Dakahlia, Egypt, 35516
        • Omar Abd El-Fattah Abd El-Maksoud

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patients must present with at least four posterior primary compound proximal caries involving two surfaces, specifically occluso-mesial or occluso-distal cavities, with a corresponding International Caries Detection and Assessment System (ICDAS) score of 4 or 5.
  • The buccolingual width of the lesion should be approximately less than two-thirds of the intercuspal distance.
  • Teeth to be restored must be in normal occlusion with the natural antagonist teeth.
  • Vital teeth with no signs of pulpal inflammation or pathological lesions.
  • Normal periodontal status and good oral hygiene.
  • Good likelihood of recall availability.

Exclusion Criteria:

  • Patients with proximal cavities that extend beyond two surfaces or have a lesion buccolingual width greater than two-thirds of the intercuspal distance, or requiring cusp coverage.
  • Partly erupted or endodontic treated teeth.
  • Poor oral hygiene or severe periodontitis.
  • Absence of neighboring or antagonist teeth.
  • Patients with known allergy to any component of the study materials.
  • Patients with unstable medical conditions.
  • Patients with known unavailability to attend recall visits.
  • Pregnant or lactating females.
  • Patients with heavy para-functional habits, fractured, or visibly cracked teeth.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Bis-GMA-containing, HEMA-containing, one-step universal adhesive.
Each patient will randomly receive one class II restoration with one of the tested restorative systems
Each patient will receive a class II restoration using the corresponding group adhesive
Active Comparator: Bis-GMA-free, HEMA-containing, one-step universal adhesive
Each patient will randomly receive one class II restoration with one of the tested restorative systems
Each patient will receive a class II restoration using the corresponding group adhesive
Active Comparator: Bis-GMA- free, HEMA-free, acrylic-based one-step universal adhesive
Each patient will randomly receive one class II restoration with one of the tested restorative systems
Each patient will receive a class II restoration using the corresponding group adhesive
Active Comparator: Bis-GMA- containing, HEMA-containing, amide-based one-step universal adhesive
Each patient will randomly receive one class II restoration with one of the tested restorative systems
Each patient will receive a class II restoration using the corresponding group adhesive

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of functional and biological properties for each group
Time Frame: 3 years
Percentage of functional and biological properties that will be clinically assessed using recently revised World Dental Federation parameters for each restorative system group
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 23, 2024

Primary Completion (Estimated)

January 23, 2027

Study Completion (Estimated)

January 30, 2027

Study Registration Dates

First Submitted

February 6, 2024

First Submitted That Met QC Criteria

February 14, 2024

First Posted (Actual)

February 20, 2024

Study Record Updates

Last Update Posted (Actual)

May 8, 2025

Last Update Submitted That Met QC Criteria

May 5, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • A0801024 CD

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Caries Class II

Clinical Trials on One-step universal adhesive

Subscribe